SC
MRK icon

Stance Capital’s Merck MRK Stock Holding History

Stance Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Buy
14,779
+2,460
+20% +$288K 0.58% 57
2026
Q1 		$1.48M Sell
12,319
-1,678
-12% -$194K 0.72% 36
2025
Q4 		$1.47M Sell
13,997
-2,803
-17% -$263K 0.54% 47
2025
Q3 		$1.41M Buy
16,800
+890
+6% +$73.3K 0.52% 63
2025
Q2 		$1.26M Buy
+15,910
New +$1.26M 0.47% 129
2025
Q1 		– Sell
-2,017
Closed -$201K – 185
2024
Q4 		$201K Buy
+2,017
New +$208K 0.12% 55

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stance Capital's MRK Position: Q2 2026 in Review

Stance Capital increased its Merck (MRK) stake by 20% in Q2 2026, buying an estimated $288K and bringing the position to 14,779 shares worth $1.9M. The position accounts for 0.58% of the portfolio, ranked #57.

Stance Capital first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,839 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Stance Capital held 14,779 shares of Merck worth $1.9M as of Q2 2026.
  • Stance Capital bought 2,460 Merck shares in Q2 2026, an estimated $288K.
  • Merck made up 0.58% of Stance Capital's portfolio in Q2 2026, its #57 holding.
  • Stance Capital first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,839 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.